Masimo Corporation · Irvine, CA United States ·(NASDAQ (GS): MASI)

Masimo hopes to become a noble in the pulse oximetry monitoring market. The company's Signal Extraction Technology (SET) noninvasively monitors arterial blood-oxygen saturation levels and pulse rates in patients. Masimo's product range offers pulse oximeters in both hand-held and stand-alone (bedside) form. Product benefits include provision of real-time information and elimination of signal interference, such as patient movements. The company primarily markets its products globally through direct sales representatives and distributors. It also licenses SET-based products to approximately 50 medical equipment manufacturers, including Cardinal Health, Medtronic, Welch Allyn, and Zoll Medical. To read the full description, subscribe now.